Clinical Trials on Pulmonary Atresia

Total 8463 results

AstraZeneca

Terminated

Effect of Roflumilast at Acute Exacerbations of Chronic Obstructive Pulmonary Disease (TREAT)

Chronic Obstructive Pulmonary Disease With (Acute) Exacerbation

United Kingdom
Rabin Medical Center

Unknown

Acute Effect of Sildenafil on Exercise Tolerance and Functional Capacity in COPD, IPF and Post Pneumonectomy Patients

Chronic Obstructive Pulmonary Disease | Idiopathic Pulmonary Fibrosis

Israel
ADIR Association

Recruiting

Comparison of the Cardiopulmonary and Gaz-exchange Response Between the Six-minute Stepper Test and the Incremental Cardiopulmonary Exercise Testing in Patients With Chronicle Obstructive Pulmonary Disease (PH-6MST)

Chronic Obstructive Pulmonary Disease | Pulmonary Rehabilitation | 6-minute Stepper Test

France
Sociedad Española de Neumología y Cirugía Torácica

Completed

Longitudinal Study to Identify Predictive Factors of Post-thrombotic Pulmonary Hypertension

Pulmonary Hypertension | Pulmonary Thromboembolisms

Spain
Beaumont Hospital

Completed

Seasonal Trends in Pneumococcal Carriage in COPD Patients (Helios)

Chronic Obstructive Pulmonary Disease (COPD)

Ireland
Imperial College Healthcare NHS Trust
National Institute for Health Research, United Kingdom

Terminated

The Role of Ambulatory Oxygen in Improving the Effectiveness of Pulmonary Rehabilitation for COPD Patients

Chronic Obstructive Pulmonary Diseases

United Kingdom
Rigshospitalet, Denmark

Recruiting

BILACO Trial: Biliary Atresia - a Severe Complex Congenital Liver Disease (BILACO)

Cognitive Impairment | Biliary Atresia

Denmark
Medical University of Warsaw
Medtronic - MITG

Completed

3D High Resolution Anorectal Manometry in Children After Surgery for Anorectal Disorders

Children | Hirschsprung Disease | Anorectal Disorder | Anorectal Atresia

Poland
University of Michigan
Griese-Hutchinson Champions for Children's Hearts Investigator Award

Completed

Impact of Vitamin C on Endothelial Function and Exercise Capacity in Fontan-Palliated Patients

Tricuspid Atresia | Hypoplastic Left Heart Syndrome | Fontan Procedure

United States
Randall Debattista
University of Malta, Faculty of Health Sciences

Not yet recruiting

Effect of NMES on Quadriceps Muscle Strength and Endurance in Patients With COPD (NMES)

Chronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
Hospital Clinic of Barcelona

Completed

Sildenafil Effects on Pulmonary Haemodynamics and Gas Exchange in Chronic Obstructive Pulmonary Disease (COPD) (SIL-COPD-01)

Chronic Obstructive Pulmonary Disease | Pulmonary Hypertension

Spain
Centre Hospitalier Universitaire de Nice

Recruiting

An Atlas of Airways at a Single Cell Level in Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis and Controls (DISCOVAIR)

Pulmonary Disease, Chronic Obstructive | Interstitial Pulmonary Fibrosis

France
Bellerophon Pulse Technologies

Completed

Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD

Chronic Obstructive Pulmonary Disease | Pulmonary Hypertension

United States
Bellerophon

Terminated

Effect iNO on Functional Respiratory Imaging in Subjects With WHO Group 3 Pulmonary Hypertension With COPD on Oxygen

Chronic Obstructive Pulmonary Disease | Pulmonary Hypertension | COPD

Belgium
United Therapeutics

Terminated

A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD) (PERFECT)

Chronic Obstructive Pulmonary Disease | Pulmonary Hypertension

United States, Israel, Argentina, Puerto Rico
Actelion

Terminated

Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease | Pulmonary Hypertension

United States, Spain, France
Carmel Medical Center

Unknown

Inhaled Iloprost for Disproportionate Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease (COPD) (COPDVEN)

Chronic Obstructive Pulmonary Disease

Israel
Rigshospitalet, Denmark
Odense University Hospital; Technical University of Denmark

Not yet recruiting

The Intestinal Innate Immune System in Newborns. Development and Inflammation in Health and Disease (INTINE)

Preterm Infants | Atresia; Bowel | Term Infants | Innate Inflammatory Response | Necrotising Enterocolitis

Denmark
University Medical Center Groningen

Recruiting

Virtual Bronchoscopic Navigation to Increase Diagnostic Yield in Patients With Pulmonary Nodules (NAVIGATOR)

Pulmonary Nodules, Solitary

Netherlands
Beijing Chao Yang Hospital

Completed

Effects of High-intensity Noninvasive Positive Pressure Ventilation in AECOPD

Acute Exacerbation of Chronic Obstructive Pulmonary Disease

China
University of Zurich

Completed

Retrospective Data Analysis of Data From the Zurich PH Registry

Pulmonary Hypertension | Pulmonary Artery Hypertension | Chronic Thromboembolic Pulmonary Hypertension

Switzerland
AstraZeneca

Completed

Clinical Outcome of Corticosteroids in the Treatment of COPD Exacerbations in China (CONTAIN)

Acute Exacerbation of Chronic Obstructive Pulmonary Disease

China
Newcastle-upon-Tyne Hospitals NHS Trust
AstraZeneca; Newcastle University

Completed

Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2)

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Brigham and Women's Hospital

Completed

Intravenous Indocyanine Green for Localization of Intra-thoracic Lesions

Pulmonary Nodule, Solitary | Pulmonary Nodule, Multiple

United States
Mylan Inc.
Theravance Biopharma

Completed

A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Participants With COPD

Chronic Obstructive Pulmonary Disease (COPD)

United States
University Hospital, Ghent
GlaxoSmithKline; University Ghent

Completed

Pharmaceutical Care for Chronic Obstructive Pulmonary Disease (COPD) Study. (PHARMACOP)

Chronic Obstructive Pulmonary Disease (COPD)

Belgium
Optimum Patient Care
Respiratory Effectiveness Group; Boehringer Ingelheim Pharmaceutical Company... and other collaborators

Unknown

Advancing the Patient Experience in Chronic Obstructive Pulmonary Disease (APEX COPD) (APEX COPD)

Chronic Obstructive Pulmonary Disease (13645005)

United States
Poitiers University Hospital

Completed

Interest of Branched Chain Amino Acids Associated With a Respiratory Rehabilitation Program in Patients Broncho Chronic Obstructive Pulmonary Disease (REHABAAR)

Broncho Chronic Obstructive Pulmonary Disease

France
AstraZeneca

Completed

A Phase IIa Study to Investigate the Efficacy and Safety of AZD7624 in Chronic Obstructive Pulmonary Disease (COPD) Patients While on Maintenance Therapy

Chronic Obstructive Pulmonary Disease COPD

United States, Netherlands, Argentina, South Africa, Chile, Peru
Laval University
Maltais, Francois, M.D.; Saey, Didier, M.D.

Completed

Chen-style Tai Chi in Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)

Canada
Sunovion Respiratory Development Inc.

Completed

A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-5)

Chronic Obstructive Pulmonary Disease (COPD)

United States, Czechia, Hungary, Russian Federation
University of Aarhus

Completed

Beetroot Juice - Effects on Performance in Chronic Obstructive Pulmonary Disease Patients (COPD)

Chronic Obstructive Pulmonary Disease Moderate

Denmark
AstraZeneca

Completed

Efficacy and Safety of Aclidinium Bromide at Two Dose Levels Versus Placebo Administered in Chronic Obstructive Pulmonary Disease (COPD) Patients

Chronic Obstructive Pulmonary Disease (COPD)

Germany, Czech Republic, France, Hungary, Italy, Peru, Poland, Russian Federation, South Africa, Spain, Ukraine
AstraZeneca

Completed

Effect of Roflumilast on Lung Function in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Salmeterol: The EOS Study (BY217/M2-127) (EOS)

Chronic Obstructive Pulmonary Disease (COPD)

Austria, Belgium, Canada, France, Germany, Italy, Netherlands, South Africa, Spain, United Kingdom
AstraZeneca

Completed

Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The HERMES Study (BY217/M2-125)

Chronic Obstructive Pulmonary Disease (COPD)

Germany, Spain, United States, Canada, India, Italy, Poland, South Africa
AstraZeneca
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-06)

Chronic Obstructive Pulmonary Disease (COPD)

Japan
Nuvaira, Inc.

Completed

Innovative Pulmonary Solutions (IPS) System for Targeted Lung Denervation (IPS-I)

Chronic Obstructive Pulmonary Disease (COPD)

Netherlands, South Africa
Novartis Pharmaceuticals

Completed

Comparison of Long-term Safety of the Combination Product QVA149A Against Placebo and Standard of Care Treatment in Chronic Obstructive Pulmonary Disease Patients With Moderate to Severe Airflow Limitation

Chronic Obstructive Pulmonary Disease (COPD)

Colombia, India, Korea, Republic of, Poland, Croatia, Estonia, Hungary, United Kingdom, Israel, Latvia, Turkey, Argentina, Panama, Mexico, Russian Federation, Serbia, Slovenia
University Medical Center Groningen

Terminated

Respiratory EMG for NIV Titration in Stable COPD Patients

Chronic Obstructive Pulmonary Disease (COPD)

Netherlands
University Hospital, Tours

Completed

Evaluation of Benefit of Nebulized Bronchodilators at Home in Severe Chronic Obstructive Pulmonary Disease and Very Severe Steady State (Nebuadom)

Severe Chronic Obstructive Pulmonary Disease

France
Air Liquide Santé International
ITEC Services; Lincoln Medical and Mental Health Center

Completed

The COPD Patient Management European Trial (COMET) (COMET)

Chronic Obstructive Pulmonary Disease (COPD)

France, Spain, Germany, Italy
Aveiro University
Fundação para a Ciência e a Tecnologia

Completed

Home-monitoring and Adherence of Patients With COPD to Long-term Rehabilitation

Chronic Obstructive Pulmonary Disease (COPD)

Portugal
Universidade Federal de Pernambuco
Conselho Nacional de Desenvolvimento Científico e Tecnológico

Unknown

Whole Body Vibration in Chronic Obstructive Pulmonary Disease (COPD) Patients

Chronic Obstructive Pulmonary Disease (COPD)

Brazil
Air Force Military Medical University, China

Unknown

Study of Bosentan in the Treatment of Stable Severe Chronic Obstructive Pulmonary Disease Patients (BTCOPD)

Chronic Obstructive Pulmonary Disease (COPD)

China
Pulmatrix Inc.
Quotient Clinical

Completed

A Safety, Pharmacokinetic and Pharmacodynamic Study of PUR0200 in COPD Patients

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
University of Edinburgh
The Dunhill Medical Trust

Completed

HELPing Older People With Very Severe Chronic Obstructive Pulmonary Disease Towards the End of Their Lives: Developing, Piloting and Refining a Practical Intervention (HELP-COPD) (HELP-COPD)

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Universidade Federal de Sao Carlos

Completed

Physical Training and Heart Rate Variability in COPD

Chronic Obstructive Pulmonary Disease (COPD)

Brazil
Helse Stavanger HF

Completed

Readmissions to Hospital Among Patients With COPD After Telemedicine Video Consultation - a Pilot Project

Chronic Obstructive Pulmonary Disease (COPD)

Norway
Hospital de Mataró

Completed

Urban Walking Circuits

Severe Chronic Obstructive Pulmonary Disease

Spain
GlaxoSmithKline

Completed

Safety And Anti-Inflammatory Effect Of SB681323 In Patients With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive | Chronic Obstructive Pulmonary Disease (COPD)

Denmark, Germany, Netherlands, Finland, United Kingdom

Clinical Trials on Pulmonary Atresia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Montenegro

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations